Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 221.31 |
| Open | 220.04 |
| Bid | 214.50 x 1200 |
| Ask | 245.88 x 1100 |
| Day's Range | 217.55 - 221.48 |
| 52 Week Range | 49.03 - 229.00 |
| Volume | 83,521 |
| Avg. Volume | 147,359 |
| Market Cap | 2.6B |
| Beta (5Y Monthly) | 1.53 |
| PE Ratio (TTM) | 27.68 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 4.52 (2.04%) |
| Ex-Dividend Date | Dec. 21, 2020 |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Simply Wall St.
If You Like EPS Growth Then Check Out Medifast (NYSE:MED) Before It's Too Late
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
- Investor's Business Daily Video
Strong Move For Medifast From Flat Base
Medifast moves past 208.67 buy point of flat base .
- Zacks
The Zacks Analyst Blog Highlights: B&G Foods, Hain Celestial, Medifast and United Natural Foods
The Zacks Analyst Blog Highlights: B&G Foods, Hain Celestial, Medifast and United Natural Foods
© 2021 Verizon Media. All rights reserved.
